Valuation: Becton, Dickinson and Company

Market Cap 52.3B 44.82B 41.93B 38.33B 72.34B 5,008B 73.11B 496B 193B 2,515B 196B 192B 8,320B P/E 2026 *
37x
P/E 2027 * 20.6x
Enterprise Value 68.18B 58.43B 54.66B 49.98B 94.31B 6,529B 95.31B 647B 252B 3,278B 256B 250B 10,847B EV / Sales 2026 *
3.53x
EV / Sales 2027 * 3.36x
Free-Float
73.18%
Yield 2026 *
2.04%
Yield 2027 * 2.08%
1 day-0.49%
1 week+4.85%
Current month+15.28%
1 month+22.11%
3 months+29.23%
6 months+4.62%
Current year-1.62%
1 week 180.72
Extreme 180.72
193.07
1 month 157.09
Extreme 157.09
193.07
Current year 140.11
Extreme 140.11
213.08
1 year 140.11
Extreme 140.11
213.08
3 years 140.11
Extreme 140.11
283.5
5 years 140.11
Extreme 140.11
287.32
10 years 140.11
Extreme 140.11
287.32
Manager TitleAgeSince
Chief Executive Officer 53 2020-01-27
Director of Finance/CFO 44 2025-12-04
Compliance Officer - 2023-01-31
Director TitleAgeSince
Director/Board Member 75 2002-09-23
Director/Board Member 71 2010-07-25
Chairman 53 2021-04-27
Date Insider Type Main position Quantity % Market Cap.
8/13/26 Fiscal year

Chief Executive Officer

129,834 0.0471%
8/11/26 Sell

EVP and President, EMEA

-2,438 0.0009%
8/6/26 Free

Director

189 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-0.55%+4.85%-1.91%-31.07% 52.3B
-0.03%+5.83%-11.43%+12.58% 202B
-0.17%+2.88%+1.27%+14.98% 119B
+1.64%+3.47%+12.17%+80.89% 60.69B
0.00%-6.57%+30.31%+56.72% 52.38B
-0.79%+2.99%+20.34%-9.48% 34.85B
+0.83%-0.97% - - 30.06B
-0.64%+1.24%+41.95%-10.42% 24.85B
+1.03%-2.88%-5.22%+24.87% 23.84B
-0.41%+3.10%-4.67%+5.48% 23.2B
Average +0.12%+0.45%+9.20%+16.06% 62.35B
Weighted average by Cap. +0.10%+1.91%+2.68%+18.06%

Financials

2026 *2027 *
Net sales 19.29B 16.53B 15.47B 14.14B 26.68B 1,847B 26.97B 183B 71.16B 928B 72.43B 70.86B 3,069B 19.73B 16.91B 15.82B 14.46B 27.29B 1,889B 27.58B 187B 72.79B 949B 74.09B 72.49B 3,139B
Net income 1.44B 1.23B 1.15B 1.05B 1.99B 138B 2.01B 13.63B 5.3B 69.07B 5.39B 5.28B 229B 2.34B 2B 1.88B 1.71B 3.24B 224B 3.27B 22.19B 8.63B 112B 8.78B 8.59B 372B
Net Debt 15.88B 13.61B 12.74B 11.64B 21.97B 1,521B 22.21B 151B 58.6B 764B 59.64B 58.35B 2,527B 13.95B 11.96B 11.19B 10.23B 19.3B 1,336B 19.5B 132B 51.47B 671B 52.38B 51.25B 2,219B
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
26-08-24 $190.96 -0.54% 662,806
26-08-21 $192.00 +2.33% 2,524,521
26-08-20 $187.62 +0.01% 1,972,683
26-08-19 $187.60 +3.78% 2,164,452
26-08-18 $180.77 -0.72% 1,616,422
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
192.00USD
Average target price
194.42USD
Spread / Average Target
+1.26%

Quarterly revenue - Rate of surprise